Invention Grant
- Patent Title: Cartilage regeneration composition containing HAPLN1 as active ingredient
-
Application No.: US16805420Application Date: 2020-02-28
-
Publication No.: US11213572B2Publication Date: 2022-01-04
- Inventor: Dae Kyong Kim , Ji Min Jang
- Applicant: HAPLNSCIENCE INC.
- Applicant Address: KR Gyeonggi-do
- Assignee: HAPLNSCIENCE INC.
- Current Assignee: HAPLNSCIENCE INC.
- Current Assignee Address: KR Gyeonggi-do
- Agency: Klarquist Sparkman, LLP
- Priority: KR10-2017-0109422 20170829,KR10-2018-0098497 20180823
- Main IPC: A61K38/39
- IPC: A61K38/39 ; A61K9/00 ; A61P19/00 ; A61P19/04 ; A23L33/10 ; A61K31/728

Abstract:
Provided is a method of regenerating cartilage tissues by treatment with hyaluronan and proteoglycan link protein 1 (HAPLN1), and a composition for regenerating cartilage, the composition including HAPLN1 as an active ingredient. According to the present disclosure, the HAPLN1 protein may have cartilage formation-stimulating ability and articular cartilage regeneration ability, may increase an expression level of TGF-β receptor I of chondrocytes to increase a component ratio of cells having cartilage formation ability, and to induce regeneration of cartilage tissues. Accordingly, the HAPLN1 protein of the present disclosure, which is a novel composition regulating TGF-β signaling, may be usefully applied as a pharmaceutical composition for regenerating cartilage, a health food composition for regenerating cartilage, or a reagent composition for regenerating cartilage.
Public/Granted literature
- US20200276278A1 CARTILAGE REGENERATION COMPOSITION CONTAINING HAPLN1 AS ACTIVE INGREDIENT Public/Granted day:2020-09-03
Information query
IPC分类: